Naomi Kelman Appointed to National Vision’s Board of Directors

More Images
DULUTH, Ga.—National Vision Holdings, Inc. (NASDAQ: EYE), appointed Naomi Kelman, former CEO and president at Willow, to its board of directors, effective Sept. 14. “We are so excited to have Naomi join our board of directors,” said Reade Fahs, CEO at National Vision. “We developed a deep respect for Naomi a decade ago—during the five years she so successfully ran Johnson and Johnson’s contact lens business for the Americas. Her subsequent experience in digital transformation and the development of disruptive products, along with her success at scaling health care models will be valuable to National Vision as we continue our growth trajectory.”

Kelman’s career spans nearly four decades. She most recently served as the first CEO and president at Willow, an innovative medtech company, from 2014 to 2019. The Silicon Valley-based company revolutionized the breast pump industry. Under her leadership, the concept of a consumer-facing wearable pump went from prototype to the marketplace in approximately three years, and is now a trusted brand for Millennials. The device was selected as one of Time magazine’s 25 Best Inventions of 2017.

Prior to joining Willow, Kelman was the first woman on the executive committee of Novartis as the division head of the global over-the-counter division of Novartis. Previously, Kelman had a long and distinguished career at Johnson & Johnson where she held multiple executive and management roles, including as president of Vistakon (Acuvue contact lenses) and Lifescan (One Touch diabetes monitor). She has also worked at Clairol and American Express. Before starting her career, Kelman earned a bachelor’s degree and Masters in Business Administration from Cornell University.